Sai Life Sciences, headquartered in India, is a prominent player in the medical, precision, and optical instruments sector. Founded in 1999, the company has established itself as a leader in providing innovative solutions across various domains, including pharmaceuticals and biotechnology. With a strong operational presence in key regions, Sai Life Sciences focuses on contract research, development, and manufacturing services, catering to a diverse clientele.
The company is renowned for its commitment to quality and precision, offering a range of core products and services that stand out in the competitive landscape. Notable achievements include significant partnerships and collaborations that have bolstered its market position. Sai Life Sciences continues to drive advancements in the industry, making it a trusted name for clients seeking excellence in medical and precision instruments.
+3 vs industry average
Sai Life Sciences’s score of 30 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sai Life Sciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Sai Life Sciences's reported carbon emissions
Sai Life Sciences, an India-based company operating in the Medical, precision and optical instruments, watches and clocks sector, has outlined significant commitments to reduce its carbon emissions. The company has set targets for achieving net-zero CO2 emissions by around 2050 and also has a commitment for net-zero CO2 emissions after 2070. In terms of emissions reporting, for the year 2024, Sai Life Sciences reported a total of approximately 34.5 million kg CO2e across Scope 1 and Scope 2 emissions, with Scope 1 emissions amounting to about 15.6 million kg CO2e and Scope 2 emissions totalling approximately 16.0 million kg CO2e. Scope 3 emissions for 2024 included approximately 0.5 million kg CO2e for business travel, about 1.2 million kg CO2e for employee commute, and 1.7 million kg CO2e for upstream transportation and distribution. Looking at previous years, for 2023, total emissions were approximately 30.2 million kg CO2e, comprising about 12.6 million kg CO2e from Scope 1 and approximately 17.5 million kg CO2e from Scope 2. Scope 3 emissions in 2023 included approximately 0.5 million kg CO2e for business travel, about 1.2 million kg CO2e for employee commute, 1.9 million kg CO2e for upstream transportation and distribution, and 2.3 million kg CO2e for downstream transportation and distribution. In 2022, the company reported Scope 1 emissions of approximately 9.8 million kg CO2e and Scope 2 emissions of about 16.1 million kg CO2e. Emissions for 2021 were approximately 12.5 million kg CO2e (Scope 1) and 16.3 million kg CO2e (Scope 2). For 2020, Scope 1 emissions were around 14.7 million kg CO2e and Scope 2 emissions were about 20.3 million kg CO2e. In 2019, Scope 1 emissions were approximately 15.3 million kg CO2e and Scope 2 emissions were about 19.9 million kg CO2e. Sai Life Sciences has also committed to Science Based Targets initiative (SBTi) goals. These include a commitment to reduce absolute Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 58.8% by the financial year 2035, using FY2024 as a base year. Furthermore, the company aims to reduce Scope 3 GHG emissions, specifically from purchased goods and services, capital goods, fuel- and energy-related activities, upstream transportation and distribution, business travel, and employee commuting, by 63.8% per INR value added within the same timeframe. These targets are classified as 1.5°C aligned.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sai Life Sciences’s Climate Goals (2030 & 2050)
1 goal2070
Net-zero CO2 emissions are achieved after 2070
Net-zero CO2 emissions are achieved after 2070
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 1 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
4 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Sai Life Sciences
Frequently asked questions
Common questions about Sai Life Sciences’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project